https://www.selleckchem.com/products/bl-918.html
BACKGROUND Clinical management of vaso-vagal syncope (VVS) remains challenging since no therapy has proven to completely prevent VVS recurrence. OBJECTIVE The purpose of this study was to analyze the mid-term outcome of cryoballoon (C cardioneuroablation achieved by pulmonary vein isolation (PVI) in patients with VVS. METHODS Patients who underwent CB cardioneuroablation in our centers between January 2014 to June 2018 were included. All patients had a history of VVS or pre-syncope despite therapeutic attempts with medical and/or pacin
Curtir
Comentario
Compartilhar
